Literature DB >> 26063434

Human Papillomavirus Infectious Entry and Trafficking Is a Rapid Process.

Justyna Broniarczyk1, Paola Massimi2, Martina Bergant3, Lawrence Banks4.   

Abstract

UNLABELLED: Previous studies have indicated that human papillomavirus (HPV) infectious entry is slow, requiring many hours after initial infection for the virus to gain entry into the nucleus. However, intracellular transport pathways typically are very rapid, and in the context of a natural HPV infection in a wounded epithelium, such slow intracellular transport would seem to be at odds with a normal viral infection. Using synchronized cell populations, we show that HPV trafficking can be a rapid process. In cells that are infected in the late S-early G₂/M phase of the cell cycle, HPV16 pseudovirion (PsV) reporter DNA gene expression is detectable by 8 h postinfection. Likewise, reporter DNA can be visualized within the nucleus in conjunction with PML nuclear bodies 1 h to 2 h postinfection in cells that are infected with PsVs just prior to mitotic entry. This demonstrates that endosomal trafficking of HPV is rapid, with mitosis being the main restriction on nuclear entry. IMPORTANCE: HPV infectious entry appears to be slow and requires mitosis to occur before the incoming viral DNA can access the nucleus. In this study, we show that HPV trafficking in the cell actually is very rapid. This demonstrates that in the context of a normal virus infection, the cell cycle state will have a major influence on the time it takes for an incoming virus to enter the nucleus and initiate viral gene expression.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26063434      PMCID: PMC4524062          DOI: 10.1128/JVI.00722-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  HPV-16 E7 functions at the G1 to S phase transition in the cell cycle.

Authors:  L Banks; S C Barnett; T Crook
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

2.  Generation of HPV pseudovirions using transfection and their use in neutralization assays.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  Methods Mol Med       Date:  2005

3.  Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.

Authors:  N D Christensen; J Dillner; C Eklund; J J Carter; G C Wipf; C A Reed; N M Cladel; D A Galloway
Journal:  Virology       Date:  1996-09-01       Impact factor: 3.616

4.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

5.  Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry.

Authors:  Gilles Spoden; Lena Kühling; Nicole Cordes; Bettina Frenzel; Martin Sapp; Klaus Boller; Luise Florin; Mario Schelhaas
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

6.  SNX17 facilitates infection with diverse papillomavirus types.

Authors:  Martina Bergant; Lawrence Banks
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

7.  Direct binding of retromer to human papillomavirus type 16 minor capsid protein L2 mediates endosome exit during viral infection.

Authors:  Andreea Popa; Wei Zhang; Megan S Harrison; Kylia Goodner; Teymur Kazakov; Edward C Goodwin; Alex Lipovsky; Christopher G Burd; Daniel DiMaio
Journal:  PLoS Pathog       Date:  2015-02-18       Impact factor: 6.823

Review 8.  The biology and life-cycle of human papillomaviruses.

Authors:  John Doorbar; Wim Quint; Lawrence Banks; Ignacio G Bravo; Mark Stoler; Tom R Broker; Margaret A Stanley
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

9.  Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.

Authors:  Wei Zhang; Teymur Kazakov; Andreea Popa; Daniel DiMaio
Journal:  mBio       Date:  2014-09-16       Impact factor: 7.867

10.  Large scale RNAi reveals the requirement of nuclear envelope breakdown for nuclear import of human papillomaviruses.

Authors:  Inci Aydin; Susanne Weber; Berend Snijder; Pilar Samperio Ventayol; Andreas Kühbacher; Miriam Becker; Patricia M Day; John T Schiller; Michael Kann; Lucas Pelkmans; Ari Helenius; Mario Schelhaas
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

View more
  16 in total

Review 1.  Human papillomavirus molecular biology.

Authors:  Mallory E Harden; Karl Munger
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-05       Impact factor: 5.657

Review 2.  Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G Guion; Martin Sapp
Journal:  Virus Res       Date:  2016-10-29       Impact factor: 3.303

3.  Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.

Authors:  Miriam Becker; Lilo Greune; M Alexander Schmidt; Mario Schelhaas
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

4.  Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes.

Authors:  Malgorzata Bienkowska-Haba; Wioleta Luszczek; Timothy R Keiffer; Lucile G M Guion; Stephen DiGiuseppe; Rona S Scott; Martin Sapp
Journal:  Cell Microbiol       Date:  2017-01-23       Impact factor: 3.715

5.  Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.

Authors:  Justyna Broniarczyk; Paola Massimi; David Pim; Martina Bergant Marušič; Michael P Myers; Robert L Garcea; Lawrence Banks
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

6.  The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry.

Authors:  Alex Lipovsky; Asu Erden; Eriko Kanaya; Wei Zhang; Mac Crite; Clinton Bradfield; John MacMicking; Daniel DiMaio; John W Schoggins; Akiko Iwasaki
Journal:  J Gen Virol       Date:  2017-10-23       Impact factor: 3.891

Review 7.  The Role of Nuclear Antiviral Factors against Invading DNA Viruses: The Immediate Fate of Incoming Viral Genomes.

Authors:  Tetsuro Komatsu; Kyosuke Nagata; Harald Wodrich
Journal:  Viruses       Date:  2016-10-22       Impact factor: 5.048

8.  Translocation of the papillomavirus L2/vDNA complex across the limiting membrane requires the onset of mitosis.

Authors:  Christine M Calton; Matthew P Bronnimann; Ariana R Manson; Shuaizhi Li; Janice A Chapman; Marcela Suarez-Berumen; Tatum R Williamson; Sudheer K Molugu; Ricardo A Bernal; Samuel K Campos
Journal:  PLoS Pathog       Date:  2017-05-02       Impact factor: 6.823

9.  The VPS4 component of the ESCRT machinery plays an essential role in HPV infectious entry and capsid disassembly.

Authors:  Justyna Broniarczyk; David Pim; Paola Massimi; Martina Bergant; Anna Goździcka-Józefiak; Colin Crump; Lawrence Banks
Journal:  Sci Rep       Date:  2017-03-28       Impact factor: 4.379

10.  HPV-16 virions can remain infectious for 2 weeks on senescent cells but require cell cycle re-activation to allow virus entry.

Authors:  Justyna Broniarczyk; Nadja Ring; Paola Massimi; Mauro Giacca; Lawrence Banks
Journal:  Sci Rep       Date:  2018-01-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.